| The influence of growth hormone replacement on heart rate variability in adults with growth hormone deficiency. | |
| | |
MedLine Citation:
|
PMID: 11422118 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Growth hormone (GH) deficiency is associated with increased cardiovascular morbidity and mortality. Abnormalities in heart rate variability (HRV), a surrogate marker of cardiac autonomic tone, have also been found in untreated growth hormone deficient (GHD) patients. Similar abnormalities have been found in patients with complications postmyocardial infarction. DESIGN AND MEASUREMENTS: This study was designed to investigate whether GH treatment leads to normalization of cardiac autonomic tone. HRV measurements were obtained from 15 minute resting ECG recordings in 11 untreated adult GHD patients (7 females; mean age 39.2 years), 10 GHD patients (6 females; mean age 46.2 years) reCENving GH replacement (mean duration, 52.7 months) and 12 healthy controls (7 females; mean age 44.6 +/- 2.9 years) who were all of similar age, weight and BMI. The untreated GHD patients were then commenced on GH and HRV measurements repeated after 3 and 6 months of treatment. RESULTS: In accord with our previous findings, HRV analysis using Fast Fourier Transform (FFT) showed a distinct pattern of abnormality in GHD patients compared with controls. Specifically, there was an increase in nHF power (P = 0.04) and a reduction in nLF power (P = 0.04) (representing parasympathetic and sympathetic activity, respectively), a reduction in nVLF power (P = 0.03) and a 50% reduction in LF/HF ratio (P = 0.02) (a measure of sympathovagal balance) in GHD patients when compared with controls. HRV results in patients who have been on long-term GH replacement were indistinguishable from controls. After 3 months GH replacement in the untreated GHD patient group, nVLF power had increased by 28% (P = 0.03) at 3 months and this was sustained at 6 months. However, no significant changes in LF and HF power were seen. CONCLUSIONS: These results suggest that abnormalities of the cardiac autonomic system in GHD patients may be correctable. Longer duration of prospective follow-up will be required to determine at what time point improvements in the other frequency bands occur. |
| | |
Authors:
|
K S Leong; P Mann; M Wallymahmed; I A MacFarlane; J P Wilding |
Related Documents
:
|
10741688 - Effects of long-term treatment with gh in the bone mineral density of adults with hypop... 8073428 - Long term follow-up of cushing's disease treated with reserpine and pituitary irradiati... 16060918 - The role of growth hormone in determining birth size and early postnatal growth, using ... 2694978 - Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. 3588258 - The effect of adjuvant oxygen therapy on transcutaneous po2 and healing in the below-kn... 20973868 - The effect of combined steroid and calcium channel blocker injection on human hypertrop... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical endocrinology Volume: 54 ISSN: 0300-0664 ISO Abbreviation: Clin. Endocrinol. (Oxf) Publication Date: 2001 Jun |
Date Detail:
|
Created Date: 2001-06-25 Completed Date: 2001-07-26 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0346653 Medline TA: Clin Endocrinol (Oxf) Country: England |
Other Details:
|
Languages: eng Pagination: 819-26 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Analysis of Variance Case-Control Studies Electrocardiography / drug effects Female Follow-Up Studies Growth Hormone / deficiency*, therapeutic use Heart Rate / drug effects* Humans Male Middle Aged Signal Processing, Computer-Assisted Statistics, Nonparametric |
| Chemical | |
Reg. No./Substance:
|
9002-72-6/Growth Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ...
Next Document: A novel mutation (N233K) in the transactivating domain and the N756S mutation in the ligand binding ...